- Intermediate
- Varenicline tartrate 230615-70-0
- Aprepitant 287930-73-8
- Aprepitant 127852-28-2
- Aprepitant 287930-75-0
- Aprepitant 200000-59-5
- Aprepitant 155742-64-6
- Aprepitant 252742-72-6
- Fosaprepitant Dimeglumine 990-91-0
- Fosaprepitant Dimeglumine 265121-01-5
- Vildagliptin 207557-35-5
- Vildagliptin 702-82-9
- Efinaconazole 144230-50-2
- Efinaconazole 133775-25-4
- Efinaconazole 127000-90-2
- Gadoterate Meglumine
- Mirabegron
- Luliconazole 98873-55-3
- Luliconazole 126534-31-4
- Atazanavir sulfate
- Bortezomib 179324-87-9
- Bortezomib 114457-94-2
- Bortezomib 205393-22-2
- Brinzolamide
- Rivaroxaban Intermediate 446292-08-6
- Rivaroxaban Intermediate 446292-07-5
- Cinacalcet Hydrochloride 1005450-55-4
- Cinacalcet Hydrochloride 585-50-2
- Eletriptan Intermediate
- Indacaterol intermediate 312753-53-0
- Indacaterol intermediate 173140-90-4
- Sitagliptin Intermediate
- Fosanavir Calcium Intermediate
News Center
Rivaroxaban intermediate 446292-07-5
【Catalogue Number】AP8106
【CAS #】446292-07-5
【Molecular Formula】C22H19N3O6
【Molecular Weight】421.40
Alias |
Intermediate of Rivaroxaban |
Catalog Number |
AP8106 |
CAS # |
446292-07-5 |
Molecular Formula |
C22H19N3O6 |
Molecular Weight |
421.40 |
Structural Formula |
|
Product Introduction CAS 446292-07-5 |
2-[(2R) -2-hydroxy-3-[[4- (3-oxo-4-morpholinyl) phenyl] amino] propyl] -1H-isoindole- 1,3 (2H) -dione, English name 2-[(2R) -2-Hydroxy-3-[[4- (3-oxo-4-morpholinyl) -phenyl] amino] propyl]-1H-isoindole-1,3 (2H) -dione, American Chemical Abstracts Registration Number is cas 446292-07-5. 2-[(2R) -2-hydroxy-3-[[4- (3-oxo-4-morpholinyl) phenyl] amino] propyl] -1H-isoindole-1,3 (2H) -Dione (CAS 446292-07-5) is an intermediate of rivaroxaban. Rivaroxaban is used in adult patients undergoing elective hip or knee replacement surgery to prevent venous thrombosis (VTE). It can also be used to prevent stroke and non-central nervous system embolism in patients with non-valvular atrial fibrillation and reduce the risk of coronary artery recurrence. |
VIWIT 沪ICP备12014533号-2 Terms of Use